Based on the conflicting results obtained by others using DSP-4 in neurotoxin-based models of PD, DSP-4 treatment either enhanced dopaminergic neuron degeneration [4–6] or failed to disrupt dopamine levels in the brain [24]. Here, DUSP26 is linked to Parkinson disease.